Quick Read FDA's New Draft Guidance On Data Integrity For In Vivo BABE Studies

The FDA has released a draft guidance, Data Integrity for In Vivo Bioavailability and Bioequivalence Studies. This article shares a concise summary.

Related Keywords

Susan Shockey ,Us Food Drug Administration ,Human Services ,Department Of Health ,Data Integrity ,Vivo Bioavailability ,Bioequivalence Studies ,Quality Control ,For Public Comments By June ,Draft Guidance ,Integrating Data Integrity ,Why Invest ,Quality Management System ,Clarkston Consulting ,